Medicare Enrolled

Dr. Oleg Gligich, M.D

Internal Medicine · Miami Beach, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
4306 ALTON RD, Miami Beach, FL 33140
3055353300
In practice since 2011 (14 years)
NPI: 1215224126 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gligich from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gligich? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gligich

Dr. Oleg Gligich is an internal medicine specialist in Miami Beach, FL, with 14 years of NPI registration. Based on federal Medicare data, Dr. Gligich performed 495 Medicare services across 200 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gligich received a total of $34,256 from 83 pharmaceutical and/or device companies across 1222 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gligich is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ 495 Medicare services $34,256 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 131522 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
495
Medicare services
Bottom 37% in FL for internal medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
200
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~35 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 407 $78 $252
Office visit, established patient (20-29 min) 28 $54 $165
Hospital follow-up visit, moderate complexity 24 $69 $228
Initial hospital admission, moderate complexity 22 $114 $449
New patient office visit, complex (60-74 min) 14 $159 $552
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$34,256
Total received (2018-2024)
Avg $4,894/year across 7 years
Top 2% in FL for internal medicine
83
Companies
1,222
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,107 (64.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,776 (25.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,374 (9.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,520
2023
$8,052
2022
$6,349
2021
$6,741
2020
$4,483
2019
$1,317
2018
$795

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$3,467
BeiGene USA, Inc.
$2,202
Daiichi Sankyo Inc.
$2,091
E.R. Squibb & Sons, L.L.C.
$1,969
Celgene Corporation
$1,877
NOVARTIS PHARMACEUTICALS CORPORATION
$1,838
Janssen Biotech, Inc.
$1,611
Karyopharm Therapeutics Inc.
$1,570
Novartis Pharmaceuticals Corporation
$1,305
PFIZER INC.
$1,157
Genentech USA, Inc.
$1,100
Astellas Pharma US Inc
$1,010
Amgen Inc.
$863
Janssen Scientific Affairs, LLC
$829
Merck Sharp & Dohme Corporation
$785
Seagen Inc.
$659
GENZYME CORPORATION
$604
Incyte Corporation
$587
BeiGene, Ltd.
$525
Merck Sharp & Dohme LLC
$511
ABBVIE INC.
$333
Tempus AI, Inc
$314
EMD Serono, Inc.
$314
ARRAY BIOPHARMA INC
$312
Bayer HealthCare Pharmaceuticals Inc.
$308
Sumitomo Pharma America, Inc.
$281
Eisai Inc.
$264
Lilly USA, LLC
$249
GlaxoSmithKline, LLC.
$241
Pharmacyclics LLC, An AbbVie Company
$234
G1 Therapeutics, Inc.
$227
Epizyme, Inc.,
$222
Pharmacyclics LLC, an AbbVie Company
$207
Exelixis Inc.
$204
ADC Therapeutics America, Inc.
$181
EISAI INC.
$170
Sirtex Medical Inc
$165
Gilead Sciences, Inc.
$162
Mirati Therapeutics, Inc.
$143
Kite Pharma, Inc.
$140
Myovant Sciences Inc.
$134
Myriad Genetic Laboratories, Inc.
$132
Adaptive Biotechnologies Corporation
$132
Alexion Pharmaceuticals, Inc.
$132
SERVIER PHARMACEUTICALS LLC
$131
Janssen Pharmaceuticals, Inc
$128
AbbVie Inc.
$128
AVEO Pharmaceuticals, Inc.
$125
TAIHO ONCOLOGY, INC.
$122
MorphoSys, US Inc.
$112
SpringWorks Therapeutics, Inc.
$106
Foundation Medicine, Inc.
$100
Ipsen Biopharmaceuticals, Inc
$93
Genmab U.S., Inc.
$92
Bayer Healthcare Pharmaceuticals Inc.
$91
ImmunoGen, Inc.
$90
Deciphera Pharmaceuticals Inc.
$81
Kyowa Kirin, Inc.
$80
Boehringer Ingelheim Pharmaceuticals, Inc.
$80
Rigel Pharmaceuticals, Inc.
$77
Dova Pharmaceuticals
$65
Regeneron Healthcare Solutions, Inc.
$62
CTI BioPharma Corp.
$53
Takeda Pharmaceuticals U.S.A., Inc.
$52
Clovis Oncology, Inc.
$51
Acceleron Pharma, Inc.
$50
Partner Therapeutics, Inc.
$49
Stemline Therapeutics Inc.
$47
JAZZ PHARMACEUTICALS INC.
$46
SANOFI-AVENTIS U.S. LLC
$45
Apellis Pharmaceuticals, Inc.
$40
Taiho Oncology, Inc.
$34
Blueprint Medicines Corporation
$32
Sun Pharmaceutical Industries Inc.
$32
RefleXion Medical, Inc.
$30
MEDIVATION FIELD SOLUTIONS LLC
$29
Pharmacosmos Therapeutics Inc.
$25
Epizyme, Inc.
$25
Aveo Pharmaceuticals, Inc.
$24
AbbVie, Inc.
$21
Advanced Accelerator Applications
$20
BIOVERATIV THERAPEUTICS INC.
$15
AMAG Pharmaceuticals, Inc.
$15
Top 3 companies account for 22.7% of total payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AKEEGA · ALIMTA · ALPROLIX · AYVAKIT · Alecensa · Avastin · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · Doptelet · ELAHERE · ELITEK · ELREXFIO · EMEND · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Elahere · Empaveli · Enhertu · Epkinly · FERAHEME · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Idhifa · Imbruvica · JAKAFI · JEMPERLI · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LEUKINE · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRISK · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · ONUREG · OPDIVO · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POLIVY · POTELIGEO · PROMACTA · PROSTATE CANCER - DISEASE · Padcev · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · REFLEXION MEDICAL RADIOTHERAPY SYSTEM · RETEVMO · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SUTENT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (64%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for internal medicine in FL.

Equivalent to $6,920 per 100 Medicare services performed
Looking for an internal medicine specialist in Miami Beach?
Compare internal medicine physicians in the Miami Beach area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
2,083
Per 100K population
77.6
County median income
$68,694
Nearest hospital
MOUNT SINAI MEDICAL CENTER OF FLORIDA, INC
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gligich is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 2% of FL peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gligich experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gligich performed 407 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gligich receive payments from pharmaceutical companies?
Yes. Dr. Gligich received a total of $34,256 from 83 companies across 1,222 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gligich's costs compare to other internal medicine physicians in Miami Beach?
Dr. Gligich's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gligich) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →